It seeks to explain biological function in terms of molecular structure, dynamics and organization, from single molecules to supramolecular structures. Replicating natural silk spinning is of ...

For comparison, Pfizer reported yesterday that Abrysvo made full-year sales of $890 million, which - while respectable - were well below its competitor. However, it brought in $515 million in the ...

Often known as the central science, it is a creative discipline chiefly concerned with atomic and molecular structure and its change, for instance through chemical reactions. A one-dimensional ...

ACS Publications’ commitment to publishing high-quality content continues to attract impactful research that addresses the world’s most important challenges.

The American Chemical Society expects its members to adhere to the highest ethical and safety standards. Indeed, the Federal Charter of the Society (1937) explicitly ...

It's notable, however, that Arexvy's main rival in the RSV vaccine space – Pfizer's Abrysvo – held up much better in the third quarter, with sales slipping only around 5% to $356 million.

Pfizer's bivalent prefusion F RSV vaccine (Abrysvo) was also granted an expanded approval to include the prevention of lower respiratory tract disease caused by RSV in high-risk adults ages 18 to 59.

[SMM Analysis] Does the Significant Price Increase Signal Reversal in the Lithium Hydroxide Market? Lithium carbonate futures and spot markets, along with lithium sector in stock market soared across ...

Among the new products, Pfizer’s RSV vaccine, Abrysvo, recorded sales of $356 million in the third quarter compared with $56 million in the previous quarter. Abrysvo revenues beat the Zacks ...